We are in the throes of yet another widespread measles epidemic, this one worse than the 2015 outbreak at Disneyland. This time it has spread to pockets in several states, including Washington, Oregon, and New York, as well as to several countries in Europe.
Infectious Diseases
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers Susan S. Huang, M.D., M.P.H, Raveena Singh, M.A., Charles C. Bailey, Jr., M.D., James D. Leo, M.D., and Loren G. Miller, M.D., M.P.H. et al., for the Project CLEAR Trial Abstract Background Hospitalized patients who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) are at high risk for infection after discharge.
Read the source article at The New England Journal of Medicine
Ineffective immunization: Vaccine storage too often fails to meet standards
Ineffective immunization: Vaccine storage too often fails to meet standards Carmen Heredia Rodriguez Kaiser Health News Friday Feb 15, 2019 at 1:01 AM By correcting one potential error, the Ventura County (Calif.) Health Care Agency accidentally made another — and jeopardized vaccines given to thousands of people in the process. In October 2017, county health officials, concerned that vaccines were getting too warm while being transported to clinics, changed their protocol.
Vitamin D May Improve Bone Health In Those Taking Anti-HIV Drug
NIH study suggests benefits for young people on long-term tenofovir treatment
Vitamin D may help prevent hormonal changes that can lead to bone loss among those being treated for HIV with the drug tenofovir, according to the results of a National Institutes of Health network study of adolescents with HIV.
Tenofovir is widely used to treat HIV infection. However, the drug causes symptoms that resemble those of vitamin D deficiency ods.od.nih.gov/factsheets/VitaminD-QuickFacts, causing bones to lose calcium and reducing bone density. The study found that large monthly doses of vitamin D reduced blood levels of a hormone that stimulates calcium release from bones.
“What we’ve found suggests vitamin D could be used to counteract one of the major concerns about using tenofovir to treat HIV,” said Rohan Hazra, M.D., of the Pediatric, Adolescent and Maternal AIDS Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the NIH institute that funds the networks. “People in their teens and twenties may be on anti-HIV treatment for decades to come, so finding a safe and inexpensive way to protect their long-term bone health would be a major advance.”
The findings were published online in Clinical Infectious Diseases.
Vitamin D helps the body absorb calcium to build bones. When the body is deficient in vitamin D, levels of a hormone called parathyroid hormone rise. This rise triggers activity that draws calcium from bones. As a result, the bones become more fragile and can break more easily. Parathyroid hormone also tends to be elevated in people taking tenofovir, whether or not they have sufficient vitamin D.
Because parathyroid hormone levels are elevated in people taking tenofovir in much the same way as they are in people with vitamin D deficiency, the researchers theorized that vitamin D might counteract the bone-depleting effects of tenofovir.
The study was conducted by first author Peter L. Havens, M.D., of the Medical College of Wisconsin and Children’s Hospital of Wisconsin, Milwaukee; Dr. Hazra; Kathleen Mulligan, Ph.D., of the University of California at San Francisco; and other researchers affiliated with the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) and the International Maternal–Pediatric–Adolescent AIDS Clinical Trials (IMPAACT) Group.
In addition to funding from NICHD, funding was also provided by the National Center for Research Resources, the National Institute on Drug Abuse, and the National Institute of Mental Health.
About 200 18- to 25-year-olds on antiretroviral therapy took part in the study. Study participants included young adults taking tenofovir and those receiving other forms of anti-HIV treatment. Each month, the adolescents and young adults in the study took a 50,000-unit dose of vitamin D or placebo. At the end of the three months, parathyroid hormone levels had fallen about 14 percent among participants taking tenofovir and vitamin D but remained unchanged in participants taking other kinds of anti-HIV medication. However, youth taking tenofovir still had higher parathyroid hormone levels than those on other anti-HIV drugs. The researchers don’t know if longer treatment with vitamin D would further reduce parathyroid hormone levels.
The recommended daily dose of vitamin D is 600 units. The authors noted that they observed no adverse effects from the vitamin D treatment during the 3 months of this study.
The researchers are now making plans for a two-year follow-up study to examine the longer-term safety of vitamin D in a similar group of HIV-infected youth taking antiretroviral regimens containing tenofovir, and to determine if the changes in parathyroid hormone result in improvements in bone density.
About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit the Institute’s website at http://www.nichd.nih.gov/.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
Story Source:
The above story is reprinted from materials provided by National Institutes of Health.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Disclaimer: Views expressed in this article do not necessarily reflect those of PreventiveMedicineDaily or its staff.
Green Valley Food Corp. is Expanding Its Recall to Include Additional Products Because of a Possible Health Risk
Green Valley Food Corp. is expanding its recall to include the following items because of a possible health risk.
- “Let’s Grow Healthy Together!” Alfalfa Sprouts 5 oz. containers with the UPC number 714722228818
- “Let’s Grow Healthy Together!”Spicy Sprouts 5 oz. containers with the UPC number 71472222991
- Alfalfa Sprouts 4oz. clamshell UPC number 815098001088
“100% Natural Onion Sprouts” 4oz. clamshell UPC number 815098002054Green Valley Food Corp. is recalling approximately 35,159 cases of a variety of products because they have the potential to be contaminated with Listeria monocytogenes. Random samples tested positive for Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.
Any customer who received any of the products on 12/07/2011 to 1/1/2012 are affected in this recall and/or if the items have a use by date ranging from 12/22/2011 to 1/17/2012. The original recall was initiated on 12/23/11 and 12/24/11, we are adding the additional items mentioned in this recall.
The items affected in the recall are as follows , which includes all items from the original press release from 12/23/2011:
- Let’s Grow Healthy Together!” Alfalfa Sprouts 5 oz. plastic 2 piece containers with the UPC number 714722228818
- Let”s Grow Healthy Together!” Spicy Sprouts 5 oz. plastic 2 piece containers with the UPC number 714722229914
- Alfalfa Sprouts 4oz. plastic security sealed clamshell UPC number 815098001088
- Green Valley Food Corp.” Onion Sprouts” 4oz. plastic security sealed clamshell UPC number 815098002054
- Let’s Grow Healthy Together!” Sunflower Greens 5 oz. plastic 2 piece containers with the UPC number 714722206069
- Let’s Grow Healthy Together!” Clover Sprouts 5 oz. plastic 2 piece containers with the UPC number 714722225510
- Let’s Grow Healthy Together!” Onion Sprouts 2 oz. plastic 2 piece containers with the UPC number 714722227712
- Let’s Grow Healthy Together!” Zesty Sprouts 5 oz. plastic 2 piece containers with the UPC number 714722221116
- Let’s Grow Healthy Together!” Organic Wheat Grass 6oz. plastic 2 piece containers with the UPC number 714722608122
- Let’s Grow Healthy Together!” Mung Bean Sprouts 8oz. red polypropylene bag with the UPC number 815098001071
- Let’s Grow Healthy Together!” Mung Bean Sprouts 16 oz. clear polypropylene bag with a green label, the UPC number 714722208162
- &Green Valley Food Corp. Spicy Sprouts 4 oz. plastic security sealed clamshell containers with the UPC number 815098002023
- Green Valley Food Corp.” Snow Pea Shoots 3 oz. plastic security sealed clamshell containers with the UPC number 714722106062
- “Green Valley Food Corp.” Organic Wheatgrass 4 oz. plastic security sealed clamshell containers with UPC number 714722608122
- Green Valley Food Corp.” Daikon Sprouts 3 oz. plastic security sealed clamshell containers with UPC number 714722206076
- Broccosprouts” Sandwich Blend 4 oz. plastic security sealed clamshell containers with UPC number 815098000289
- Broccosprouts” Salad Blend 4 oz. plastic security sealed clamshell containers with UPC number 815098000265
- Broccosprouts” Deli Blend 4 oz. plastic security sealed clamshell containers with the UPC number 815098000272
- Broccosprouts” Broccoli Sprouts 4 oz. plastic security sealed clamshell containers with UPC number 815098000258
The sprouts affected in this recall were distributed via truck deliveries to all customers in Texas. Our customers consist on grocery store distribution centers and food service customers
Till this present day there has bee no related illnesses CONFIRMED because of this recall. This is a cautionary measure taken by Green Valley Food Corp. to assure safe and quality products are being distributed by our facility.
On 12/12/2011 a random sample was taken from a customer the product tested positive for Salmonella. Green Valley Food Corp. voluntarily recalled the alfalfa-based products when we were notified of the positive result on 12/23/2011 and 12/24/2011. On 12/21/2011 random samples were taken of our facility, several samples had a positive result for Listeria monocytogenes. To assure our customers of safe products, Green Valley Food Corp., is voluntarily recalling the additional items listed, which consist of “Let’s Grow Healthy Together”, “Green Valley Food Corp.” and “BroccoSprouts” branded products. This is a voluntary cautionary measure taken by Green Valley Food Corp. to assure all customers and consumers of any issues with our products. We are voluntarily requesting this recall and are working closely with the FDA to assure all consumers our products are safe.
If you are a direct customer affected by this recall you will be receiving a letter asking for the quantities you were shipped and their whereabouts.
Consumers who purchased these product at your local grocery store should dispose of the products immediately in a trash receptacle.
Should you have any questions please feel free to contact us at (214) 939-3900 from Monday thru Friday from 6:00am to 4:00pm and on Saturday from 6:00am to noon, or via email at info@greenvalleyfood.com. We thank you for your attention to this recall and know with the help of the FDA, Green Valley Food Corp., will continue to produce and ship safe and quality products.
Story Source:
The above story is reprinted from materials provided by FDA.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Disclaimer: Views expressed in this article do not necessarily reflect those of PreventiveMedicineDaily or its staff.